Literature DB >> 7275277

Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions.

G F Webster, U R Nilsson, W P McArthur.   

Abstract

Activation of the alternative pathway of complement is known to be initiated by bacterial structures. We have fractionated Propionibacterium acnes cells, purified various cell fractions, and tested their complement-activating ability in human serum chelated with ethyleneglycol bis-(beta-aminoethylether)-N,N1-tetraacetic acid. The majority of complement-activating activity was localized in the wall fraction. This activity was resistant to lipid extraction, protease, RNAse, DNAse and lysozyme treatment. NaIO4, formamide, and hot (but not cold) trichloroacetic acid (TCA) extraction ablated the complement-activating capacity of cell walls. Compounds removed by extraction failed to consume significant hemolytic activity against antibody-coated sheep erythrocytes (EA). Addition of TCA-extracted soluble material to cell wall suspensions resulted in an inhibition of hemolytic consumption by the cell wall. These results indicate that, in P. acnes, complement-activating molecules are located in the cell wall and are carbohydrate in nature. Peptidoglycan, lipid, protein, and nucleic acid do not appear to contribute to the cell wall's ability to activate complement.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7275277     DOI: 10.1007/BF00914205

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  29 in total

1.  Activation of the alternative pathway by pneumococcal cell walls.

Authors:  J A Winkelstein; A Tomasz
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

2.  Anticomplementary activity of antitumour polysaccharides.

Authors:  T Okuda; Y Yoshioka; T Ikekawa; G Chihara; K Nishioka
Journal:  Nat New Biol       Date:  1972-07-12

3.  Complement activation by Propionibacterium acnes and Bacteroides melaninogenicus.

Authors:  K Okuda; K Yanagi; I Takazoe
Journal:  Arch Oral Biol       Date:  1978       Impact factor: 2.633

4.  Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall.

Authors:  J Greenblatt; R J Boackle; J H Schwab
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

5.  The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.

Authors:  H A Verbrugh; W C Van Dijk; R Peters; M E Van Der Tol; J Verhoef
Journal:  Immunology       Date:  1979-07       Impact factor: 7.397

6.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

7.  Activation of the alternative complement pathway by L-phase variants of gram-positive bacteria.

Authors:  F T Saulsbury; J A Winkelstein
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Anticomplementary activity of Fusobacterium polymorphum in normal and C4-deficient sources of guinea pig complement.

Authors:  C E Hawley; W A Falkler
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

9.  Cell wall composition and deoxyribonucleic acid similarities among the anaerobic coryneforms, classical propionibacteria, and strains of Arachnia propionica.

Authors:  J L Johnson; C S Cummins
Journal:  J Bacteriol       Date:  1972-03       Impact factor: 3.490

10.  Chemotaxigenesis and complement fixation by Listeria monocytogenes cell wall fractions.

Authors:  L A Baker; P A Campbell; J R Hollister
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

View more
  4 in total

1.  Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro.

Authors:  G F Webster; J J Leyden; R A Musson; S D Douglas
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

2.  Arthropathic properties of cell wall polymers from normal flora bacteria.

Authors:  S A Stimpson; R R Brown; S K Anderle; D G Klapper; R L Clark; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

3.  Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris.

Authors:  Teruaki Nakatsuji; Yu-Tsueng Liu; Cheng-Po Huang; Christos C Zoubouis; Richard L Gallo; Chun-Ming Huang
Journal:  J Invest Dermatol       Date:  2008-05-08       Impact factor: 8.551

4.  Activation of the alternative complement pathway by pneumococcal lipoteichoic acid.

Authors:  D S Hummell; A J Swift; A Tomasz; J A Winkelstein
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.